AU1968399A - Pharmaceutical compositios containing (s)-cefuroxime axetil and their use for the treatment of bacterial infections - Google Patents

Pharmaceutical compositios containing (s)-cefuroxime axetil and their use for the treatment of bacterial infections

Info

Publication number
AU1968399A
AU1968399A AU19683/99A AU1968399A AU1968399A AU 1968399 A AU1968399 A AU 1968399A AU 19683/99 A AU19683/99 A AU 19683/99A AU 1968399 A AU1968399 A AU 1968399A AU 1968399 A AU1968399 A AU 1968399A
Authority
AU
Australia
Prior art keywords
compositios
pharmaceutical
treatment
bacterial infections
cefuroxime axetil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19683/99A
Inventor
David Samuel Deutsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU1968399A publication Critical patent/AU1968399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU19683/99A 1997-12-19 1998-12-17 Pharmaceutical compositios containing (s)-cefuroxime axetil and their use for the treatment of bacterial infections Abandoned AU1968399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9726781 1997-12-19
GBGB9726781.9A GB9726781D0 (en) 1997-12-19 1997-12-19 Pharmaceutical composition
PCT/EP1998/008208 WO1999032124A1 (en) 1997-12-19 1998-12-17 Pharmaceutical compositios containing (s)-cefuroxime axetil and their use for the treatment of bacterial infections

Publications (1)

Publication Number Publication Date
AU1968399A true AU1968399A (en) 1999-07-12

Family

ID=10823845

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19683/99A Abandoned AU1968399A (en) 1997-12-19 1998-12-17 Pharmaceutical compositios containing (s)-cefuroxime axetil and their use for the treatment of bacterial infections

Country Status (3)

Country Link
AU (1) AU1968399A (en)
GB (1) GB9726781D0 (en)
WO (1) WO1999032124A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002057227A2 (en) * 2001-01-19 2002-07-25 Rhodia/Chirex, Inc. Process of enantiomerically enriched flavor and fragrance components
HRP20020924A2 (en) * 2001-11-23 2003-10-31 Glaxo Group Ltd Pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil

Also Published As

Publication number Publication date
GB9726781D0 (en) 1998-02-18
WO1999032124A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
AU2663097A (en) Compounds and methods for the selective treatment of cancer and bacterial infections
AU1618697A (en) Novel compounds and pharmaceutical use thereof
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
GR3036015T3 (en) Substituted oxazolidinone and their use as antibacterial medicine
AP9701092A0 (en) Use of fumagilol and derivateves thereof for preparing medicaments against intestinal infections
AU663833B2 (en) Surgical and/or clinical apparatus
HUP0002662A3 (en) Pharmaceutical compositions containing lysostaphin alone or in combination with an antibiotic for the treatment of staphylococcal infections
HUP9901437A3 (en) Pharmaceutical formulation, containing amoxycillin and clavulanate
AU2508597A (en) Drug for the treatment of tumours
AU2749395A (en) Medical use of bromelain
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU2387097A (en) Substituted benzylamines and their use for the treatment of depression
AU3760400A (en) Methods and reagents for the diagnosis and treatment of multiple sclerosis
AUPN801196A0 (en) New cephem compounds and pharmaceutical use thereof
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
AU4063197A (en) Antimicrobial medical devices and methods of production and use
AUPN907296A0 (en) Biocontrol agents for use in treatment of opportunistic infections
AU4812393A (en) Use of rapamycin in the treatment of aids
AU1820499A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU1181897A (en) Medical use of proteases
AU3530395A (en) Treatment of viral infections
AU1968399A (en) Pharmaceutical compositios containing (s)-cefuroxime axetil and their use for the treatment of bacterial infections
AU1712395A (en) Medical application of bromelain
AU4604697A (en) Compositions and methods for the treatment of human cytomegalovirus infection
GB9419571D0 (en) Treatment of oral infections

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase